NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson's disease. [electronic resource]
Producer: 20011011Description: 391-400 p. digitalISSN:- 0953-816X
- Amphetamine -- pharmacology
- Amyloid beta-Protein Precursor -- drug effects
- Animals
- Antibodies -- pharmacology
- Caspase 3
- Caspases -- drug effects
- Cell Survival -- drug effects
- DNA Fragmentation -- drug effects
- Disease Models, Animal
- Dopamine -- metabolism
- Fluorescent Dyes -- pharmacology
- Genetic Vectors -- physiology
- Immunohistochemistry
- Male
- Movement Disorders -- drug therapy
- Neostriatum -- metabolism
- Nerve Degeneration -- drug therapy
- Nerve Tissue Proteins -- genetics
- Neural Pathways -- metabolism
- Neuronal Apoptosis-Inhibitory Protein
- Neurotoxins -- pharmacology
- Oxidopamine -- pharmacology
- Parkinsonian Disorders -- drug therapy
- Rats
- Rats, Wistar
- Substantia Nigra -- metabolism
- Sympatholytics -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.